Clinical trials with anti-aging supplements

Comprehensive evaluation of changes in blood dynamics due to anti-aging supplement intake - Clinical trials with anti-aging supplements

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045205

Enrollment

Registered

2021-08-20

Start date

2021-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

not application

Interventions

250mg/day Anti-aging ingredients for 12 weeks Placebo for 12weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men and women over 40 years old at the time of obtaining consent to participate in the examination

Exclusion criteria

Exclusion criteria: 1) Suffering from or history of serious hepatic disorder, renal, cardiac, pulmonary, or gastrointestinal (including gastrectomy) disease, diabetes, food allergy, or other serious disease 2) Taking medications which are related to affectung outcomes in this study. 3)Participating other clinical trials

Design outcomes

Primary

Measure	Time frame
NMN-related substance testing in the blood (NMN, NAD, NAM) Sirtuin genetic testing	—

Secondary

Measure	Time frame
Hormone testing, liver function, lipids, blood count, va-scular testing (ABI/PWV), bone density,AGEs,8-OHdG	—

Countries

Japan

Contacts

Public ContactSachi Uehata

Supplements Department Supplements Laboratory

suehata@dhc.co.jp043-275-4811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026